Table 2.
Ovarian tumor tissues.
| No. | Age (Yr) |
Histologic Type | Grade | hTERT mRNA Expression |
Telomerase Activity |
Telomere Length | Telomere Fusion |
|---|---|---|---|---|---|---|---|
| OT1 | 42 | papillary serous cystadenocarcinoma, nos | II | + | + | 4.80 | − |
| OT2 | 75 | papillary serous cystadenocarcinoma, nos | III | + | + | 4.34 | + |
| OT3 | 78 | papillary serous cystadenocarcinoma, nos - low malignant potential | II | + | + | 4.42 | + |
| OT4 | 65 | mixed papillary serous cystadenocarcinoma and endometriod carcinoma | III | + | + | 3.89 | + |
| OT5 | 50 | serous cystadenocarcinoma, nos | II | + | + | 3.64 | + |
| OT6 | 80 | serous cystadenocarcinoma, nos | III | + | + | 3.79 | + |
| OT7 | 52 | mixed carcinoma (endometriod and mucinous), nos | I | + | + | 6.50 | + |
| OT8 | 56 | carcinoma, nos, borderline serous tumor with intraepithelial carcinoma | III | + | + | 5.21 | + |
| OT9 | 80 | carcinoma, nos, 80% tumor, 20% necrosis | III | + | + | 5.22 | + |
| OT10 | 77 | carcinoma, nos | I | + | + | 6.83 | − |
| OT11 | 58 | carcinoma, nos | high | + | − | 6.16 | − |
| OT12 | 65 | carcinoma, nos | high | + | + | 4.60 | + |
| OT13 | 57 | adenocarcinoma, nos | III | + | + | 6.17 | − |
| OT14 | 70 | adenocarcinoma, nos | high-grade | + | + | 7.14 | − |
| OT15 | 56 | adenocarcinoma, nos | II | + | + | 5.45 | − |
| OT16 | 46 | adenocarcinoma, nos | II | + | + | 7.06 | − |
| OT17 | 60 | adenocarcinoma, nos | IIIC | + | + | 4.81 | − |
| OT18 | 58 | papillary adenocarcinoma, nos | I | + | + | 4.47 | − |
| OT19 | 79 | papillary carcinoma, nos | IIIC | + | + | 3.66 | − |
| OT20 | 52 | clear cell adenocarcinoma, nos | III | − | + | 5.51 | − |
| OT21 | 44 | clear cell adenocarcinoma, nos | III | + | + | 3.72 | − |
| OT22 | 50 | serous carcinoma | III | + | + | 4.42 | − |
| OT23 | 48 | serous adevocarcinoma | III | + | + | 4.30 | + |
| OT24 | 56 | poor differentiated adenocarcinoma | III | + | + | 4.57 | − |
| OT25 | 60 | Papillary serous adenocarcinoma | III | + | + | 6.79 | − |
| OT26 | 70 | Endometrioid | III | + | + | 4.63 | + |
| OT27 | 65 | Papillary serous adenocarcinoma | III | + | + | 5.27 | − |
| OT28 | 64 | Papillary serous carcinoma | III | + | + | 5.41 | − |
| OT29 | 69 | mucinous | III | + | + | 6.93 | − |
| OT30 | 58 | mixed with papillary serous carcinoma and clear cell | III | + | + | 5.92 | + |
| OT31 | 74 | Papillary serous adenocarcinoma | III | + | + | 6.60 | + |
| OT32 | 60 | serous cystadenocarcinoma, nos | II | + | + | 4.47 | + |
| OT33 | 61 | poor differentiated adenocarcinoma | III | + | + | 5.66 | − |
| OT34 | 82 | Papillary serous carcinoma | III | + | + | 5.40 | + |
| OT35 | 64 | Papillary serous carcinoma | II | + | + | 4.80 | + |
| OT36 | 53 | serous carcinoma | III | + | + | 4.97 | − |